Vincent P. Sandanayaka,Sharon Shechter,Sharon Shacham,Dilara McCauley,Erkan Baloglu
申请号:
US16840841
公开号:
US20200230110A1
申请日:
2020.04.06
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Compounds of formula I:and pharmaceutically acceptable salts, solvates, or hydrates thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using the compounds, salts, solvates, or hydrates and the compositions in the treatment of various disorders associated with CRM1 activity.